Perspectives in drug design against malaria

Area of Science:

• Malariology
• Medicinal Chemistry
• Parasitology

Background:

• Rising drug resistance in Plasmodium falciparum and insecticide resistance in mosquitoes are driving a resurgence of severe malaria.
• Existing antimalarial drugs face challenges due to evolving parasite resistance mechanisms.
• Novel therapeutic strategies are urgently needed to combat drug-resistant malaria strains.

Purpose of the Study:

• To provide a comprehensive overview of drug design strategies for Plasmodium falciparum malaria.
• To identify and evaluate potential molecular targets and inhibitors for antimalarial drug development.
• To highlight parasite pathways and enzymes with available structural and biochemical data for inhibitor design.

Main Methods:

• Review of existing literature on Plasmodium falciparum drug resistance and antimalarial drug discovery.
• Analysis of parasite metabolic pathways, including glycolysis, nucleotide metabolism, and redox systems.
• Examination of proteases, organelle function, and enzyme-specific inhibitors with known structural and biochemical properties.

Main Results:

• Numerous potential drug targets in Plasmodium falciparum have been identified.
• Development of clinically useful, target-specific inhibitors remains a significant challenge.
• Specific pathways and enzymes, such as those in glycolysis and nucleotide metabolism, offer promising avenues for inhibitor development.

Conclusions:

• Target-specific inhibitors for Plasmodium falciparum malaria are still a distant prospect.
• Focusing on pathways with available structural and biochemical data is crucial for advancing drug design.
• Further research into parasite metabolism and organelle function may yield novel antimalarial drug candidates.